VOLUME 70
2009
NUMBER 3

Brainstorms

310 Vasomotor Symptoms and Depression in Women, Part 2. Treatments That Cause Remission and Prevent Relapses of Major Depressive Episodes Overlap With Treatments for Vasomotor Symptoms

[PDF]

Original Articles

312 Antidepressant Use in Elderly Suicide Victims in New York City: An Analysis of 255 Cases

[Abstract] [PDF]

318 The Moderating Impact of Ethnicity on Metabolic Outcomes During Treatment With Olanzapine and Aripiprazole in Patients With Schizophrenia

[Abstract] [PDF]

326 Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double Blind, Placebo-Controlled Trial

[Abstract] [PDF]

334 Relationship of Nicotine Dependence, Subsyndromal and Pathological Gambling, and Other Psychiatric Disorders: Data From the National Epidemiologic Survey on Alcohol and Related Conditions [CME]

[Abstract] [PDF]

344 Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder: A Meta-Analysis Including 6562 Patients

[Abstract] [PDF]

354 Patient Preference as a Moderator of Outcome for Chronic Forms of Major Depressive Disorder Treated With Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or Their Combination

[Abstract] [PDF]

362 Risk Factors for Violent Crime in Schizophrenia: A National Cohort Study of 13,806 Patients [CME]

[Abstract] [PDF]

370 Mirtazapine, a Sedating Antidepressant, and Improved Driving Safety in Patients With Major Depressive Disorder: A Prospective, Randomized Trial of 28 Patients

[Abstract] [PDF]

378 Long-Term Mental Health Resource Utilization and Cost of Care Following Group Psychoeducation or Unstructured Group Support for Bipolar Disorders: A Cost-Benefit Analysis [CME]

[Abstract] [PDF]

387 An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression

[Abstract] [PDF]

397 Increased Antipsychotic Sensitivity in Elderly Patients: Evidence and Mechanisms

[Abstract] [PDF]

406 Does Interpersonal Loss Preceding Panic Disorder Onset Moderate Response to Psychotherapy? An Exploratory Study

[Abstract] [PDF]

Focus on Women's Mental Health

412 An Imperfect Literature and Evidence-Based Medicine

[PDF]

414 Selective Serotonin Reuptake Inhibitor Exposure During Early Pregnancy and the Risk of Fetal Major Malformations: Focus on Paroxetine

[Abstract] [PDF]

423 Sexual Function in Postpartum Women Treated for Depression: Results From a Randomized Trial of Nortriptyline Versus Sertraline

[Abstract] [PDF]

ASCP Corner

429 All Antipsychotics Are Equal, but Some Are More Equal Than Others

[PDF]

Letters To the Editor

431 High-Risk Groups for Charcoal-Burning Suicide Attempt in Hong Kong, China, 2004

[PDF]

431 A Preliminary Study of fMRI-Guided rTMS in the Treatment of Generalized Anxiety Disorder: 6-Month Follow-Up

[PDF]

432 Augmentation of Dopaminergic Agents for Major Depressive Disorder

[PDF]

Reply by Arun V. Ravindran, Sidney H. Kennedy, and Carin E. Binder

[PDF]

434 Correction

A roadmap to key pharmacologic principles in using antipsychotics in the treatment of older patients [Academic Highlights] (J Clin Psychiatry 2009;70[1]:131-138)

[PDF]

Book Reviews

435 Manic-Depressive Illness: Bipolar Disordersand Recurrent Depression, 2nd ed

[PDF]

435 The Mindful Brain: Reflection and Attunement in the Cultivation of Well-Being

[PDF]

436 Electroconvulsive Therapy: A Guide for Professionals and Their Patients

[PDF]

436 Experiences of Mental Health In-patient Care: Narratives From Service Users, Carers and Professionals

[PDF]

Electronic CME Activities

Available through www.psychiatrist.com/toc

e04 The Epidemiology and Recognition of Pain and Physical Symptoms in Depression

[Abstract]

e05 Diagnosing and Treating Patients With Symptoms of Depression

[Abstract]

e06 Tolerability of Antipsychotics: Recent Controversies and Future Management

[Abstract]